1985
DOI: 10.1016/0009-8981(85)90355-9
|View full text |Cite
|
Sign up to set email alerts
|

Purification and determination of the modifying protein responsible for the post-synthetic modification of creatine kinase (EC 2.7.3.2) and enolase(EC 4.2.1.11)

Abstract: SummaryThe purification of a serum protein, responsible for the postsynthetic modification of CK and enolase, is described. A purification of about 1300-fold could be reached after subsequent chromatography of human serum on DEAE cellulose and Sephacryl S-200 Superfine followed by affinity chromatography using antibodies against human serum albumin, C3 and C4 and against total human serum proteins. A recovery of 160% of modifying activity was found. The molecular mass and the isoelectric point of the modifying… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1987
1987
2005
2005

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…71,72 Enolase also undergoes postsynthetic modifications like CKMM. 73 At present, it appears that the measurement of β-enolases will not be able to differentiate between skeletal and myocardial muscle damage. An assay more specific for αβ-enolase might be more useful.…”
Section: Enolasementioning
confidence: 99%
“…71,72 Enolase also undergoes postsynthetic modifications like CKMM. 73 At present, it appears that the measurement of β-enolases will not be able to differentiate between skeletal and myocardial muscle damage. An assay more specific for αβ-enolase might be more useful.…”
Section: Enolasementioning
confidence: 99%
“…However, this possibility is excluded by the mentioned quantitative agreement between the TF antigen concentrations found in the present study and those reported in the studies quoted above for a variety of ELISAs. Apparently, the bulk of plasma TF is protected from the proteolytic fragmentation demonstrated for circulating tissue proteins, such as creatine kinase and enolase (Van Landeghem et al , 1985;), or TnT (Diris et al , 2004). Due to the lack of a membrane‐binding region, soluble TF has only a few percent of the procoagulant activity of lipidated full‐length TF (Waxman et al , 1992) and the same is true for the alternatively spliced human TF variant (ashTF) recently found by Bogdanov et al (2003).…”
Section: Discussionmentioning
confidence: 99%